Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
作者信息
Karikari Thomas K, Charway-Felli Augustina, Höglund Kina, Blennow Kaj, Zetterberg Henrik
机构信息
School of Life Sciences, Midlands Integrative Biosciences Training Partnership, University of Warwick, Coventry, United Kingdom.
Neurology Department, 37 Military Hospital, Accra, Ghana.
出版信息
Front Neurol. 2018 Mar 29;9:201. doi: 10.3389/fneur.2018.00201. eCollection 2018.
Abstract
摘要
相似文献
1
Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.评论：1990 - 2015年全球、区域和国家神经系统疾病负担：全球疾病负担研究2015的系统分析
Front Neurol. 2018 Mar 29;9:201. doi: 10.3389/fneur.2018.00201. eCollection 2018.
2
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家神经障碍负担，1990-2016 年：2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 May;18(5):459-480. doi: 10.1016/S1474-4422(18)30499-X. Epub 2019 Mar 14.
3
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家神经系统疾病负担：全球疾病负担研究2015的系统分析
Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17.
4
The burden of common neurological disorders in Asia: insights from the Global Burden of Disease Study (1990-2021).亚洲常见神经疾病的负担：全球疾病负担研究（1990 - 2021年）的见解
J Neurol. 2025 Apr 10;272(5):333. doi: 10.1007/s00415-025-13074-4.
5
Burden of neurodegenerative diseases in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease Study 2016.1990-2016 年东地中海区域神经退行性疾病负担：2016 年全球疾病负担研究的结果。
Eur J Neurol. 2019 Oct;26(10):1252-1265. doi: 10.1111/ene.13972. Epub 2019 May 31.
6
Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990-2019.全球、区域和国家神经障碍的负担和可归因风险因素：1990-2019 年全球疾病负担研究。
Front Public Health. 2022 Nov 29;10:952161. doi: 10.3389/fpubh.2022.952161. eCollection 2022.
7
Alzheimer's and dementia: Diagnosis, assessment, and disease monitoring global, regional, and national burden of Alzheimer's disease and other dementias (ADODs) and their risk factors, 1990-2021: A systematic analysis for the Global Burden of Disease study 2021.阿尔茨海默病与痴呆症：诊断、评估及疾病监测 1990 - 2021 年全球、区域和国家层面阿尔茨海默病及其他痴呆症（ADODs）及其风险因素的负担：全球疾病负担研究 2021 的系统分析
Alzheimers Dement (Amst). 2025 May 27;17(2):e70126. doi: 10.1002/dad2.70126. eCollection 2025 Apr-Jun.
8
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis.中国 1990-2010 年阿尔茨海默病和其他形式痴呆的流行病学：系统回顾和分析。
Lancet. 2013 Jun 8;381(9882):2016-23. doi: 10.1016/S0140-6736(13)60221-4.
9
Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、区域和国家阿尔茨海默病及其他类型痴呆症负担，1990-2016 年：2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2019 Jan;18(1):88-106. doi: 10.1016/S1474-4422(18)30403-4. Epub 2018 Nov 26.
10
Global and regional projections of the economic burden of Alzheimer's disease and related dementias from 2019 to 2050: A value of statistical life approach.2019年至2050年全球及区域阿尔茨海默病及相关痴呆症经济负担预测：统计生命价值法
EClinicalMedicine. 2022 Jul 22;51:101580. doi: 10.1016/j.eclinm.2022.101580. eCollection 2022 Sep.
引用本文的文献
1
Genome-wide association analyses reveal susceptibility variants linked to Parkinson's disease in the South African population using inferred global and local ancestry.全基因组关联分析利用推断的全球和本地血统揭示了南非人群中与帕金森病相关的易感变异。
medRxiv. 2025 Aug 2:2025.08.01.25331910. doi: 10.1101/2025.08.01.25331910.
2
Efficacy and safety of Yangxue Qingnao Granules in treatment of migraine: A systematic review and meta-analysis.养血清脑颗粒治疗偏头痛的疗效与安全性：一项系统评价与Meta分析
World J Clin Cases. 2024 Jan 16;12(2):335-345. doi: 10.12998/wjcc.v12.i2.335.
3
Assessment of potential drug-related problems (PDRP) and clinical outcomes in bacterial meningitis patients admitted to tertiary care hospitals.评估入住三级医院的细菌性脑膜炎患者的潜在药物相关问题（PDRP）和临床结局。
PLoS One. 2023 Oct 9;18(10):e0285171. doi: 10.1371/journal.pone.0285171. eCollection 2023.
4
Perspectives of cardiac rehabilitation in patients who had a stroke: a protocol for a qualitative study review.对曾患中风的患者的心脏康复的观点：一项定性研究综述的方案。
BMJ Open. 2023 Aug 3;13(8):e071964. doi: 10.1136/bmjopen-2023-071964.
5
Editorial: Neuroinflammation and neuroimmune response in experimental MCAO and ischemic stroke.社论：实验性大脑中动脉闭塞和缺血性卒中中的神经炎症与神经免疫反应
Front Aging Neurosci. 2023 May 11;15:1195395. doi: 10.3389/fnagi.2023.1195395. eCollection 2023.
6
Changes in Liver Lipidomic Profile in G2019S- Mouse Model of Parkinson's Disease.G2019S 突变型帕金森病小鼠模型中肝脏脂质组学谱的变化。
Cells. 2023 Mar 4;12(5):806. doi: 10.3390/cells12050806.
7
The Role of the Autonomic Nervous System in Headache: Biomarkers and Treatment.自主神经系统在头痛中的作用：生物标志物和治疗。
Curr Pain Headache Rep. 2022 Oct;26(10):767-774. doi: 10.1007/s11916-022-01079-x. Epub 2022 Sep 5.
8
Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients.瑞舒伐他汀联合 rt-PA 静脉溶栓治疗老年急性缺血性脑卒中的疗效。
Comput Math Methods Med. 2022 Jun 15;2022:9403693. doi: 10.1155/2022/9403693. eCollection 2022.
9
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility.阿尔茨海默病中的血磷酸化tau：分析、解释和临床应用。
Nat Rev Neurol. 2022 Jul;18(7):400-418. doi: 10.1038/s41582-022-00665-2. Epub 2022 May 18.
10
Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.阿尔茨海默病的血液检测：增加研究参与的广度和多样性对于广泛验证和接受至关重要。
J Alzheimers Dis. 2022;90(3):967-974. doi: 10.3233/JAD-215730.
本文引用的文献
1
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.家族性阿尔茨海默病中的血清神经丝轻链：早期神经退行性变的标志物。
Neurology. 2017 Nov 21;89(21):2167-2175. doi: 10.1212/WNL.0000000000004667. Epub 2017 Oct 25.
2
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.1990 - 2015年全球、区域和国家神经系统疾病负担：全球疾病负担研究2015的系统分析
Lancet Neurol. 2017 Nov;16(11):877-897. doi: 10.1016/S1474-4422(17)30299-5. Epub 2017 Sep 17.
3
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用：系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
4
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer's disease.神经颗粒素和YKL-40：阿尔茨海默病中突触退化和神经炎症的独立标志物。
Alzheimers Res Ther. 2015 Dec 24;7:74. doi: 10.1186/s13195-015-0161-y.
5
Epidemiology of Dementia among the Elderly in Sub-Saharan Africa.撒哈拉以南非洲地区老年人痴呆症的流行病学
Int J Alzheimers Dis. 2014;2014:195750. doi: 10.1155/2014/195750. Epub 2014 Aug 6.
6
Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.HIV 感染患者的脑脊髓液淀粉样蛋白和 tau 生物标志物。
BMC Neurol. 2009 Dec 22;9:63. doi: 10.1186/1471-2377-9-63.
Zotero 插件